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Dysfunction of central serotonin (5-HT) system has been proposed to be one of the
underlying mechanisms for anxiety and depression, and the association of diabetes
mellitus and psychiatric disorders has been noticed by the high prevalence of
anxiety/depression in patients with diabetes mellitus. This promoted us to examine
these behaviors in central 5-HT-deficient mice and those also suffering with diabetes
mellitus. Mice lacking either 5-HT or central serotonergic neurons were generated by
conditional deletion of Tph2 or Lmx1b respectively. Simultaneous depletion of both
central serotonergic neurons and pancreatic islet cells was achieved by administration of
diphtheria toxin (DT) in Pet1-Cre;Rosa26-DT receptor (DTR) mice. The central 5-HT-deficient
mice showed reduced anxiety-like behaviors as they spent more time in and entered more
often into the light box in the light/dark box test compared with controls; similar results
were observed in the elevated plus maze test. However, they displayed no differences
in the immobility time of the forced swimming and tail suspension tests suggesting
normal depression-like behaviors in central 5-HT-deficient mice. As expected, DT-treated
Pet1-Cre;Rosa26-DTR mice lacking both central serotonergic neurons and pancreatic islet
endocrine cells exhibited several classic diabetic symptoms. Interestingly, they displayed
increased anxiety-like behaviors but reduced immobility time in the forced swimming
and tail suspension tests. Furthermore, the hippocampal neurogenesis was dramatically
enhanced in these mice. These results suggest that the deficiency of central 5-HT may
not be sufficient to induce anxiety/depression-like behaviors in mice, and the enhanced
hippocampal neurogenesis may contribute to the altered depression-like behaviors in the
5-HT-deficient mice with diabetes. Our current investigation provides understanding the
relationship between diabetes mellitus and psychiatric disorders.
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INTRODUCTION
The central serotonin (5-HT) system is known to be involved
in emotion, learning and memory (Barnes and Sharp, 1999;
Duman and Voleti, 2012), and 5-HT deficiency in the brain is
believed to be a major causative factor in anxiety and depression
(Brigitta, 2002; Leonardo and Hen, 2006). Selective 5-HT
reuptake inhibitors (SSRIs), which can promote monoamine
system functions, attenuate anxiety-like behaviors (Graeff et al.,
1996) and also produce certain beneficial effects in patients with
depression (Artigas et al., 1996; Blier and Ward, 2003). They are
currently the most commonly prescribed class of antidepressants
(Santarelli et al., 2003), although the exact molecular mechanisms
behind their antidepressant effects are not fully understood. The
use of SSRIs may help to alleviate the symptoms of depression
by promoting adult neurogenesis in the hippocampus (Malberg
et al., 2000; Santarelli et al., 2003).
The global prevalence of diabetes mellitus has been steadily
increasing over the past few decades (Alberti et al., 1998; Wild
et al., 2004). The diabetes type I is caused by the destruction
of pancreatic islet endocrine cells (Butler et al., 2003), whose
normal function is to secrete hormones that regulate blood
glucose homeostasis, such as insulin (Lenoir et al., 2011). The
typical symptoms of diabetes include polyuria, polyphagia and
polydipsia as well as the elevation of blood glucose level (Alberti
et al., 1998; Cooke and Plotnick, 2008). Despite the symptoms
of diabetes mellitus and psychiatric disorders (e.g., anxiety and
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depression) are very much non-overlapping, these two disorders
are somehow co-occurred (Ciechanowski et al., 2000; Anderson
et al., 2001). For example, the prevalence of anxiety/depression
is 2–3 times higher in patients with diabetes mellitus compared
with the general population (Popkin et al., 1988; Blanz et al.,
1993), and this observation has sparked the hypothesis that an
increased risk of developing anxiety and depression may be a
complication of diabetes mellitus. Some clinical studies have also
shown that anxiety/depression may be a risk factor for diabetic
complications as well as increased morbidity and mortality from
diabetes mellitus (Anderson et al., 2001).
Our previous studies have reported that transcription factor
Lmx1b is required for the development of central serotonergic
neuron (Ding et al., 2003), and conditional deletion of this gene
results in the loss of serotonergic neurons therefore offering a
central 5-HT-deficient mouse model (Dai et al., 2008). Trypto-
phan hydroxylase (Tph2) is the key enzyme for 5-HT synthesis
in the brain (Zhang et al., 2004), and specific deletion of Tph2
leads to the central 5-HT deficiency without affecting the survival
of the serotonergic neurons (Savelieva et al., 2008; Kriegebaum
et al., 2010). The prototypical serotonergic transcription fac-
tor Pet1 is expressed in both central serotonergic neurons and
pancreatic islet cells (Hendricks et al., 1999, 2003; Ohta et al.,
2011), and Pet1-driven Cre expression was used to simultaneously
deplete these two kinds of cells in Pet1-Cre;Rosa26-diphtheria
toxin receptor (DTR) mice in adulthood. The aim of the present
study was to examine whether central 5-HT deficiency results in
abnormal anxiety- and depression-like behaviors, and to explore
the possible involvement of diabetes mellitus in these behaviors
and the underlying mechanisms.
MATERIALS AND METHODS
MICE
Mice lacking central serotonergic neurons (Pet1-Cre;
Lmx1bflox/flox) were generated by crossing Pet1-Cre mice to
flox Lmx1b mice (hereafter referred to as PC/Lmx1b) as reported
in our previous study (Dai et al., 2008). The other central
5-HT-deficient mice (Pet1-Cre;Tph2flox/flox; referred to as
PC/Tph2) used in this study were obtained by crossing Pet1-Cre
mice to flox Tph2 mice as described in our previous report
also, which contained central serotonergic neurons but failed to
synthesize 5-HT (Kriegebaum et al., 2010). To simultaneously
deplete both the central serotonergic neurons and pancreatic
islet cells, Pet1-Cre;Rosa26-DTR (referred to as PC/DTR) mice
were generated by crossing Rosa26-DTR mice (Buch et al., 2005)
to Pet1-Cre mice. In addition, Pet1-Cre/Rosa26-LacZ mice were
generated by crossing Rosa26-LacZ mice (Soriano, 1999) to Pet1-
Cre mice; this was used to examine the Cre activity in the pancreas
and brain. Furthermore, Pomc-GFP mice (Overstreet et al., 2004)
were crossed with PC/DTR mice to obtain PC/DTR/Pomc-GFP
mice, which were used to visualize immature neurons in the
subgranular zone (SGZ) of the dentate gyrus.
In the set of experiment for depleting central serotonergic neu-
rons and pancreatic islet cells, DT was intraperitoneally injected
once daily for 2 days (20 ng/g body weight; Sigma) in PC/DTR
or PC/DTR/Pomc-GFP mice and control mice. Behavioral tests
and immunostaining analysis were performed 3–4 weeks after DT
injection. Animals were group-housed (4–5 mice per cage) in a
thermo-regulated environment (22–24◦C) with ad libitum access
to water and food, and on a 12-h light/dark cycle. All animal
care and experimental protocols were approved by the Animal
Research Committees of the Kunming Institute of Zoology, Chi-
nese Academy of Sciences and the Tongji University School of
Medicine, China.
X-GAL STAINING
X-gal staining was used to detect Cre recombinase activity in
Pet1-Cre mice. Two-week old Pet1-Cre;Rosa26 mice were deeply
anesthetized, then their pancreas and brain were dissected in
cold 0.01 M phosphate buffered saline (PBS; pH 7.4), fixed in
4% paraformaldehyde in PBS for 2 h at 4◦C, rinsed briefly
in PBS and cryoprotected with 30% sucrose in PBS overnight.
Twenty-µm thick sections were then cut with a cryostat. The
sections were stained with X-gal solution containing 1 mg/ml
X-gal, 2 mM MgCl2, 5 mM K3Fe(CN)6 and 5 mM K4Fe(CN)6
for 10–16 h at 37◦C, and then slightly counterstained with neutral
red.
IMMUNOHISTOCHEMISTRY, BROMODEOXYURIDINE (BrdU) LABELING
AND IN SITU HYBRIDIZATION
After perfusing with 4% paraformaldehyde, brains were removed
and post-fixed overnight. Forty-µm brain sections were cut
and incubated with mouse anti-bromodeoxyuridine (BrdU)
(1:300; Calbiochem) or goat anti-NeuroD (1:400; Santa Cruz)
primary antibody at 4◦C overnight, followed by incubation
with the appropriate biotinylated secondary antibody (1:500;
Vector) for 3 h and Cy3-conjugated streptavidin (1:1000; Jackson
ImmunoResearch) for 1 h at room temperature. For BrdU pulse
labeling, mice were injected with BrdU (50 mg/kg body weight)
four times at 2-h intervals, and then sacrificed for analysis 2
h after the last injection. Prepared sections were treated with
0.01 M citrate buffer at 95◦C for 5 min, then incubated in 2
N HCl at 37◦C for 20 min and in 0.1 M sodium borate for 10
min, and finally washed in PBS. The treated sections were then
immunostained with mouse anti-BrdU antibody as described
above. In situ hybridization for detection of Pet1 mRNA expres-
sion was performed as reported in our previous study (Song
et al., 2011). Images were captured using a Nikon epifluorescence
microscope (Eclipse 80i) or a confocal microscope (TCS SP5,
Leica). Cell counts in the dorsal raphe nucleus and hippocampal
SGZ were performed in every sixth section from each animal.
As the factor of volumes of the counted brain regions were not
included, our counting method may lead to an overestimation or
underestimation of the real number of serotonergic neurons in
the raphe nucleus and new-born neurons in the dentate gyrus.
DIABETES RELATED EXAMINATION
Body weight was measured manually at the beginning of all
experiments. Blood glucose level was measured from the mice
tail vein blood using the glucometer (ONE TOUCH Ultra Glu-
cometer, Johnson & Johnson Medical [China] CO., Ltd.) after 3-h
fasting. The quantities of food and water intake were assessed by
a metabolic cage and the monitoring software (Panlab Harvard).
Diptheria toxin injected control mice were individually placed
Frontiers in Behavioral Neuroscience www.frontiersin.org September 2014 | Volume 8 | Article 325 | 2
Jia et al. Lacking Pet1-expressing cells induces abnormalities
in one cage and allowed free access to food and water during
a 24-h period, and the quantities were recorded at each hour;
DT-injected PC/DTR mice were treated in the same way. The
data of food and water intake were recorded by the monitoring
software.
BEHAVIORAL OBSERVATION
Adult (3–5 months old) male mice were used in the following
behavioral observation. Physiological cycle in adult female mice
may cause the instability of some hormones (e.g., estrogen),
and this may influence the behavioral performances and there-
fore complicate dissecting the relationship between the central
5-HT deficiency and behavioral studies. The experiments were
performed during 9:00 am to 17:00 pm, and animal behaviors
were videotaped. It should be noted that the behavioral data
acquisition and analysis were performed by a double-blind man-
ner; people performed these were blind to genotypes. Animals
were habituated in the test room for 2 h before starting the
experiments.
In this study, multiple mouse lines were used, and they were
generated by crossing two lines of mice thus having a mixed
genetic background. Behavioral performances are different in
different mouse stains, and the genetic background of control
mice was well controlled in the following ways. First, to minimize
the contribution of strain differences, the mice lines used in this
study have been intercrossed by sister-brother mating over seven
generations to get a congenetic background. Second, in each set
of behavioral observations, comparison was made only between
gene-modified mice (i.e., PC/Lmx1b, PC/Tph2 and PC/DTR) and
wild type mice (controls) from the same litters, which should have
the same mixed genetic background.
LIGHT/DARK BOX TEST
We used a light/dark box (ENV-510 test environment) that were
divided into two equally sized compartments (13.5 × 27 ×
20.3 cm) together with the activity monitoring software (Activity
Monitor; Med Associates) to evaluate the anxiety levels. Mice
were placed in the central light box facing the dark box and
were allowed to freely explore for 5 min. The amount of time
spent in the light box and the frequency of transitions between
the light and dark boxes were recorded. The data of PC/Tph2
mice were recorded by an experienced observer by means of a
video/computer system, while the data of PC/DTR mice were
measured by the activity monitoring software (Med Associates).
ELEVATED PLUS MAZE
Elevated plus maze (Med Associates) also was used to test anxiety-
like behaviors (Lister, 1987; Weisstaub et al., 2006), and the
platform was elevated 74 cm above the floor, which consisted
of two open (35 × 6 cm) and two closed (35 × 6 × 22 cm)
arms and a connecting central zone (6 × 6 cm). Mice were
placed on the central platform facing an open arm and were
allowed to freely explore the maze for 5 min. The amount of
time spent in the open arms and the frequency of transitions
between the open and closed arms were recorded. The data of
PC/Tph2 mice were measured by an experienced observer who
was blind to genotypes by means of a video/computer system,
while the data of PC/DTR mice were recorded by the monitoring
software.
FORCED SWIMMING TEST
This test was used to assess behavioral despair in mice, which
is often used to approximate some aspects of depression in
humans (Porsolt, 2000; Nestler et al., 2002) as described previ-
ously (Porsolt et al., 1977; David et al., 2003; Tian et al., 2011).
The apparatus consisted of a glass cylinder (24 cm height, 16
cm diameter) that was filled with water to a depth 18 cm and
maintained at 25 ± 1◦C. Mice were forced to swim 6 min, and
the time spent immobile during the last 4 min was recorded
by an experienced observer who was blind to genotype. They
were considered immobile when they stopped struggling, only
moved slightly and occasionally to keep their nose above the water
surface.
TAIL SUSPENSION TEST
Time spent immobile in this test was also used to measure
behavioral despair (Steru et al., 1985; Castagne et al., 2011).
Mice were suspended by the tail from a vertical stainless steel
hook (distance from floor: 20 cm) using adhesive tape (distance
from tip of tail: 2 cm). The immobility time was recorded by
the activity monitoring software (Med Associates, Tail suspension
system) during suspended the mice 6 min. They were considered
immobile when they hung passively without any movement.
OPEN FIELD TEST
The ENV-510 test environment equipped with infrared beams
and Activity Monitor (Med Associates) were used to evaluate
motor activity in the open field test. Mice were placed in a
Plexiglas box (27 × 27 × 20.3 cm) to freely explore the chamber
for the duration of the test session and the locomotor activity
was monitored over a 30-min period, and the data were recorded
by each beam break as one unit of exploratory activity using the
activity monitoring software (Med Associates).
ROTAROD TEST
Mice were placed on the rotating rod and the latency to fall
was measured with a 4–40 rpm accelerating speed during 5 min
(Panlab Harvard). Each mouse was tested three times at 1-h
intervals after habituating 2 min each time, and was placed on
the rod for a maximum of 15 min per trial.
STATISTICAL ANALYSIS
All data were expressed as mean ± SEM. Comparison between
two groups was conducted by unpaired Student’s t-test, the food
and water intake tests were analyzed by using a repeated measure
ANOVA followed by the Tukey Honestly Significantly Different
(HSD) test. Differences were considered statistically significant if
p< 0.05.
RESULTS
ABNORMAL BEHAVIORS IN THE CENTRAL 5-HT-DEFICIENT MICE
We first detected the anxiety- and depression-like behaviors in
PC/Tph2 mice (Pet1-Cre;Tph2flox/flox) in which Tph2, the key
enzyme for 5-HT synthesis, was deleted in the central seroton-
ergic neurons as reported previously (Kriegebaum et al., 2010).
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Inactivation of Tph2 did not affect the survival of serotonergic
neurons in the brain as revealed by the expression of Pet1 in
PC/Tph2 mice (Figures 1A,B). The spontaneous locomotor activ-
ity shown by the travelled distance in the open field was not
different between the PC/Tph2 and control mice (Figure 1C). In
the light/dark box test, PC/Tph2 mice displayed more time in the
light box (Figure 1D), and more times of entries into the light box
compared with controls (Figure 1E). Similar results were obtained
in the elevated plus maze test, shown by spending more time in
the open arms (Figure 1F) and more times of entries into the
open arms in PC/Tph2 mice compared with controls (Figure 1G).
On the other hand, in the forced swimming (Figure 1H) and
tail suspension tests (Figure 1I), no significant differences were
detected in the immobility time between the PC/Tph2 and control
mice. These results suggest that the level of anxiety-like behaviors
may be decreased but that of depression-like behaviors is likely
unchanged in PC/Tph2 mice.
The unchanged depression-like and decreased anxiety-like
behaviors in PC/Tph2 mice are somehow inconsistent with the
monoamine deficiency hypothesis of depression which is sup-
ported by the anti-depressive effect of SSRIs. To further confirm
this, we set out to examine these behaviors in PC/Lmx1b (Pet1-
Cre;Lmx1bflox/flox) mice lacking the central serotonergic neurons
(Dai et al., 2008). Reduced anxiety-like behaviors revealed by
both the elevated plus maze and novelty suppressed feeding tests
has been published in our previous study (Dai et al., 2008). Here,
we found that in the forced swimming and tail suspension tests,
PC/Lmx1b mice behaved similarly as PC/Tph2 mice; the immo-
bility time was not different from control mice (Figures 1J,K).
Taken together, these results suggest the possibility that 5-HT defi-
ciency in the brain may not be sufficient to alter the depression-
like behaviors but may lead to a reduced anxiety level in mice.
PET1-EXPRESSING CELLS ARE LOCATED IN BOTH PANCREATIC ISLET
AND RAPHE NUCLEI
Previous report has indicated that Pet1 is expressed in the
pancreatic islets and shows a restricted expression to the central
serotonergic neurons in the brain (Hendricks et al., 1999, 2003;
Ohta et al., 2011). We crossed Rosa26-DTR mice with Pet1-Cre
mice to generate the Pet1-Cre;Rosa26-DTR (PC/DTR) mice,
which led to deplete the Pet1-expressing cells: pancreatic islet cells
and central serotonergic neurons in adulthood. The PC/DTR
mice have the DTR sequence inserted into the ROSA26 locus,
downstream of a loxP-flanked STOP cassette (Buch et al., 2005).
Excision of the STOP cassette through Cre recombinase activity
therefore renders these cells susceptible to DT-mediated ablation.
We first confirmed the functional Cre recombinase by cross-
ing Pet1-Cre mice with Rosa26-LacZ reporter mice (Soriano,
1999) and assessing β-gal activity. In the peripheral system
of Pet1-Cre;Rosa26-LacZ mice, X-gal-positive staining was only
observed in the islets of the pancreas (Figures 2A,B). In our
previously published observations (Dai et al., 2008), X-gal stain-
ing was detected selectively in the central serotonergic neurons of
the raphe nuclei in the brain. We next looked at the expression of
Tph2, a specific central serotonergic neuron marker in the brain
stem. Along with Nissl staining (Figures 2C,D), Tph2 immunos-
taining revealed that the central serotonergic neurons were largely
FIGURE 1 | Decreased anxiety-like behaviors and unchanged
depression-like behaviors in the central 5-HT-deficient mice. (A, B)
Pet1-expressing cells still exist in the dorsal raphe nucleus of PC/Tph2 mice.
Scale bar: 300 µm. (C) There are no differences between PC/Tph2 mice
and controls in the total distance traveled in the open field test during a
30-min period. (D, E) In the light/dark box test, PC/Tph2 mice spend more
time in the light box (D, p < 0.01), and enter more times into the light box
compared with the control mice (E, p < 0.01). (F, G) In the elevated plus
maze test, longer time in the open arms is spent by PC/Tph2 mice
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FIGURE 1 | Continued
(F,p < 0.001), and they also enter more times into the open arms compared
with controls (G, p < 0.01). (H) Immobility time in the forced swimming
test shows no differences between PC/Tph2 mice and control mice.
(I) Immobility time in the tail suspension test is not different between
PC/Tph2 mice and control mice. (J) Immobility time in the forced
swimming test shows no differences between PC/Lmx1b mice and control
mice. (K) Immobility time in the tail suspension test shows no differences
between PC/Lmx1b mice and control mice. “n” denotes the animal number
in figures. CTL: control. All data are expressed as mean ± SEM. ** and
*** indicate p < 0.01 and p < 0.001.
depleted in the raphe nuclei of DT-treated PC/DTR mice com-
pared with controls (Figures 2E–G). Our results here indicate that
both the pancreatic islet cells and central serotonergic neurons
could be depleted by the systemic administration of DT in adult
PC/DTR mice.
DT-TREATED PC/DTR MICE EXHIBIT TYPICAL DIABETES
MELLITUS-ASSOCIATED SYMPTOMS
Functional or physical damage of pancreatic islet cells can result
in insulin deficiency, and in turn lead to the onset of diabetes
mellitus (DeFronzo et al., 1992). Therefore, we next determined
whether selective ablation of islet cells gave rise to diabetic symp-
toms in the DT-treated PC/DTR mice. We found that despite
these mice showed normal body weight (Figure 3A), they exhib-
ited increased food and water intake compared with controls
(Figures 3B,C), which are reminiscent of two classic diabetic
symptoms: polyphagia and polydipsia. In addition, the litter
in the DT-treated PC/DTR mice home cages showed obvious
signs of increased urination (Figure 3D). Importantly, blood
glucose level after a 3-h fast was profoundly increased in the DT-
treated PC/DTR mice compared with controls (Figure 3E). These
results demonstrate that DT-mediated destruction of pancreatic
islet cells leads to typical diabetic symptoms in adult PC/DTR
mice.
ALTERED ANXIETY- AND DEPRESSION-LIKE BEHAVIORS IN
DT-TREATED PC/DTR MICE
As mentioned previously, diabetes mellitus has been suggested to
be an increased risk of developing anxiety and depression. Having
observed typical symptoms of diabetes mellitus in our DT-treated
PC/DTR mice, which also lacked the central serotonergic neu-
rons, we hypothesized that anxiety- and depression-like behaviors
would be changed in these mice.
We first used the open field test to assess the changes in
locomotor activity, and found that total traveled distance was
not significantly different between the DT-treated PC/DTR and
control mice (Figure 4A). The rotarod test was used to evaluate
balancing ability, and no a significant difference was detected in
the latency to fall between the two groups in three trial tests
(Figure 4B). These results show that overall locomotor perfor-
mance is normal in DT-treated PC/DTR mice.
We used the light/dark box and elevated plus maze tests
to evaluate anxiety levels in our DT-treated PC/DTR mice.
In the light/dark box test, they spent less time in the light
box (Figure 4C) and entered it fewer times compared with
the controls (Figure 4D). In the elevated plus maze test, the
FIGURE 2 | Pet1-expressing cells are located in pancreatic islet of
Pet1-Cre;Rosa26-LacZ mice and raphe nuclei of DT-treated PC/DTR
mice. (A, B) X-gal staining reveals that Cre recombinase is specifically
expressed in the islet of the pancreas (arrows) of Pet1-Cre/Rosa26-LacZ
mice. Sections are counterstained with Neutral red. Scale bar: 90 µm.
(C, D) Nissl staining shows intensely-stained serotonergic neurons
(arrowheads) in the dorsal raphe nucleus of control mice (C), but not in
DT-treated PC/DTR mice (D). (E, F) Immunohistochemical staining shows
that nearly all Tph2-positive cells are lost from the dorsal raphe nucleus of
DT-treated PC/DTR mice (F) compared with controls (E) (p < 0.01). (G)
Quantitative analysis of the results shown in (E) and (F). CTL: control. All
data are expressed as mean ± SEM. *** p < 0.001.
DT-treated PC/DTR mice spent less time exploring the open arms
(Figure 4E) and entered into the open arms fewer times compared
with control mice (Figure 4F). These results suggest that the
anxiety levels are increased in the DT-treated PC/DTR mice.
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FIGURE 3 | DT-treated PC/DTR mice exhibit typical diabetic
symptoms. (A) Average body weight in DT-treated PC/DTR mice is
comparable to that of control mice. (B, C) Cumulative food
(B, F (1,17) = 7.007, p < 0.05) and water (C, F (1,17) = 46.184, p < 0.001)
intake levels over a 24-h period are significantly higher in DT-treated
PC/DTR mice than in controls. (D) DT-treated PC/DTR mice urinate much
more than control mice, as revealed by the overall appearance of their litter.
(E) Blood glucose levels are markedly increased in DT-treated PC/DTR mice
compared with controls (p < 0.01). CTL: control. All data are expressed as
mean ± SEM. * p < 0.05, *** p < 0.001.
We next used the forced swimming and tail suspension
tests to investigate depression-like behaviors in the PC/DTR
mice. Unexpectedly, immobility time was significantly decreased
in the forced swimming (Figure 4G) and tail suspension
tests (Figure 4H) of DT-treated PC/DTR mice, suggesting
altered depression-like behaviors. These behavioral pheno-
types were not due to any locomotor defects, because the
open field and rotarod test results were both comparable to
controls.
INCREASED ADULT HIPPOCAMPAL NEUROGENESIS IN DT-TREATED
PC/DTR MICE
Diabetic rodents induced by streptozotocin showed reduced adult
hippocampal neurogenesis (Beauquis et al., 2008; Stranahan et al.,
2008), while increased neurogenesis and cell proliferation rates
were observed in db/db mice (Ramos-Rodriguez et al., 2014),
which is a widely used genetic mouse model in diabetes research
(Sharma et al., 2003). It has been shown that most of clinically
used antidepressants (SSRIs being the most common) promote
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FIGURE 4 | Increased anxiety- but lowered depression-like behaviors in
DT-treated PC/DTR mice. (A) Total traveled distance during a 30-min
period is comparable between DT-treated PC/DTR mice and controls in the
open field test. (B) The latency to fall in the rotarod test is not significantly
different between the two groups. (C, D) In the light/dark box test,
DT-treated PC/DTR mice spend less time in the light box (C, p < 0.01), and
enter fewer times into the light box compared with the control mice
(D, p < 0.05). (E, F) In the elevated plus maze test, DT-treated PC/DTR mice
spend less time in the open arms (E, p < 0.05), and enter into them fewer
times compared with controls (F, p < 0.05). (G) Immobility time in the
forced swimming test is significantly decreased in the DT-treated PC/DTR
mice compared with the controls (p < 0.01). (H) Immobility time in the tail
suspension test is significantly reduced in DT-treated PC/DTR mice
(p < 0.05). All data are expressed as mean ± SEM. * p < 0.05, ** p < 0.01.
neurogenesis in the adult dentate gyrus, a characteristic that
is thought to be critical for their antidepressant action (Mal-
berg et al., 2000; Santarelli et al., 2003). Since our DT-treated
PC/DTR mice exhibited both diabetic symptoms and anti-
depressive behaviors, we detected whether adult hippocampal
neurogenesis was changed in these mice, which might help to
explain their behavioral phenotypes. We used BrdU to label
the dividing cells and thereby assessed adult neural stem cell
proliferation (van Praag et al., 1999; Kee et al., 2002; Taupin,
2007). Significantly more proliferating cells were observed in
SGZ of the dentate gyrus in DT-treated PC/DTR mice compared
with controls (Figures 5A–C). We also immunostained for the
basic helix-loop-helix transcription factor NeuroD, a marker of
differentiating newborn neurons (Lee et al., 1995; Miyata et al.,
1999), and observed a pronounced increase in the number of
NeuroD-positive cells in DT-treated PC/DTR mice compared
with controls (Figures 5D–F). Immature neurons in the SGZ can
be visualized also by GFP fluorescence in Pomc-GFP transgenic
mice (Overstreet et al., 2004); as expected, more GFP-positive cells
were observed in the SGZ of DT-treated PC/DTR/Pomc-GFP mice
(Figures 5G–I). Taken together, these results demonstrate that
the adult hippocampal neurogenesis is enhanced in DT-treated
PC/DTR mice.
DISCUSSION
In the present study, we found that abnormal behaviors were
observed in the two kinds of central 5-HT-deficient mice
(PC/Tph2 and PC/Lmx1b). The data from the light/dark box
and elevated plus maze tests suggest that the level of anxiety
was decreased in these central 5-HT-deficient mice, but was
increased in mice with both central 5-HT deficiency and dia-
betes (DT-treated PC/DTR mice), supporting the idea that the
diabetes is a risk factor in developing anxiety. On the other
hand, the unchanged immobility time revealed by the forced
swimming and tail suspension tests in PC/Tph2 and PC/Lmx1b
mice suggest that the central 5-HT deficiency may not be suf-
ficient to induce depression-like behaviors in mice. In addi-
tion, we generated a novel transgenic mouse model in which
Pet1-expressing cells were deleted in adulthood, and DT-treated
PC/DTR mice exhibited typical symptoms of diabetes melli-
tus, as well as increased anxiety-like but lowered depression-
like behaviors, to which the enhanced hippocampal neurogenesis
may contribute. This mouse model (PC/DTR mice) may provide
a novel insight to understand and investigate the underlying
mechanisms of the clinical comorbidity between diabetes and
psychiatric disorders.
Anxiety and depression are known to be associated with
central 5-HT deficiency (Coppen, 1967; Naughton et al., 2000),
which is supported by the facts that monoaminergic antide-
pressants attenuate anxiety-like behaviors (Graeff et al., 1996)
and also produce beneficial effects in patients with depression
(Artigas et al., 1996; Naughton et al., 2000; Blier and Ward,
2003). However, all these antidepressants including SSRIs have a
delayed onset of action, although the extracellular 5-HT level is
increased several hours after drug intake. In addition, there are
approximately one third of depressed patients that do not respond
to these antidepressants, and enhancing 5-HT reuptake by the
transporter enhancer tianeptine has a similar effect as inhibiting
5-HT reuptake by SSRIs in treating anxiety/depression (Lôo et al.,
1992; Lacasse and Leo, 2005; Duman and Aghajanian, 2012). In
this investigation, we used two kinds of central 5-HT-deficient
mouse lines to explore the level of anxiety- and depression-
like behaviors, and found that the anxiety-like behaviors were
decreased but depression-like behaviors were similar to control
mice (Figure 1). The depression-like behaviors in Tph2-deficient
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FIGURE 5 | Increased adult neurogenesis in the hippocampus of
DT-treated PC/DTR mice. (A–F) The numbers of BrdU-positive (A–C,
p < 0.01) and NeuroD-positive cells (D–F, p < 0.05) are greatly increased
in the SGZ of DT-treated PC/DTR mice compared with controls. (G–I)
Green fluorescent protein-positive cells are also markedly increased in
number in the SGZ of DT-treated PC/DTR/Pomc-GFP mice (p < 0.01).
CTL: control. All data are expressed as mean ± SEM. * p < 0.05,
** p < 0.01.
mice is still be a controversial topic: the depression-like behavior
shown by tail-suspension test was not changed in Tph2 knockout
mice (Savelieva et al., 2008), while it was increased in Tph2
knockin mice (Belmaker et al., 2008). In addition, it has been
reported that the deletion of 5-HT1A receptor in mice increased
anxiety, but reduced the immobility in the forced swimming test
(Ramboz et al., 1998). Thus, opposite effects in anxiety- and
depression-like behaviors by the manipulations of 5-HT system
are not unique in our 5-HT-deficient mice. Although it may
be argued that the forced swimming and tail suspension tests
are behavioral indexes for screening chemicals having potential
antidepressant effects in humans, they are also widely used to
characterize the depression-like behaviors in rodents (Cryan et al.,
2005). A recent finding demonstrates that ketamine, an antagonist
of the NMDA receptor, produces rapid, robust and sustained
antidepressant effects (Berton and Nestler, 2006; Duman and
Aghajanian, 2012). Thus, other mechanisms such as the glutamate
and adult hippocampal neurogenesis may play critical roles in
depression patients resistant to SSRIs treatments. Nevertheless,
our data demonstrate that 5-HT deficiency in the brain may not
be sufficient to lead to depression- and anxiety-like behaviors in
mice.
As mentioned above, a high prevalence of anxiety/depression
is present in patients with diabetes mellitus (Ciechanowski
et al., 2000; Anderson et al., 2001). After confirming the loss
of Pet1-expressing cells in our DT-treated PC/DTR mice, we
assessed them for symptoms of diabetes mellitus. As expected
from the loss of islet cells, the mice exhibited several typical
symptoms of diabetes mellitus, including polyphagia, polydip-
sia, polyuria and high blood glucose levels (Figure 3). The
increased anxiety-like behaviors were observed in DT-treated
PC/DTR mice (Figure 4), which is consistent with the con-
occurrence of diabetes mellitus and anxiety in clinical obser-
vation. On the other hand, the expected increase of the level
of depression-like behaviors was not observed. However, the
hippocampal neurogenesis was significantly increased in our
DT-treated PC/DTR mice (Figures 4, 5). In conventional Tph2
knockout mice (Klempin et al., 2013) and PC/Lmx1b mice
(unpublished observation), the adult hippocampal neurogenesis
is not changed, but it is enhanced in diabetic db/db mice (Ramos-
Rodriguez et al., 2014). Thus, it is likely the diabetic complica-
tion itself or together with the adult depletion of serotonergic
neurons leads to the enhanced hippocampal neurogenesis in DT-
treated PC/DTR mice. Previous studies have shown that the
enhanced adult hippocampal neurogenesis played critical role in
mediating SSRIs-induced antidepressant effect in mice (Malberg
et al., 2000; Santarelli et al., 2003). Running wheel training
enhances the adult hippocampal neurogenesis in rodents, and
this may be a potential mechanism of the therapeutic effects
by exercise on alleviating the symptoms of major depression as
well as other behavioral defects (Ernstn et al., 2006; Lucassen
et al., 2010; Wolf et al., 2011). It is possible that treatments
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(e.g., physical exercise), not limited to SSRIs, could promote
adult hippocampal neurogenesis may be beneficial in alleviating
depression symptoms.
Interestingly, the patients of wolfram syndrome often suffer
from depressive states, and this disease is associated with the
juvenile (non-autoimmune) diabetes. As the mouse model of wol-
fram syndrome, Wfs1-deficient mice displayed increased anxiety
but normal depression level (Luuk et al., 2009). The immobility
time of Wfs1-deficient mice in the forced swimming and tail
suspension tests did not differ from that of wild-type littermates.
However, there was augmented response to the administration
of antidepressant drugs (imipramine and paroxetine) (Visnapuu
et al., 2013). Similarly, our DT-treated PC/DTR mice also showed
increased anxiety but a lower level of depression-like behaviors.
Therefore, it may be a certain overlap of behavioral phenotypes
between the Wfs1-deficient and our DT-treated PC/DTR mice.
We supposed that 5-HT system may have some correlations with
Wfs1 gene or wolfram syndrome.
Pet1 is restricted to the serotonergic neurons in the brain,
but is not detected in non-serotonergic cells intermingled in
the raphe nuclei of the brain stem (Hendricks et al., 1999,
2003). In addition, because wild type mice were used as con-
trol, some behavioral alterations observed in the PC/DTR and
PC/Tph2 mice may be attributed to the possible subtle behav-
ioral and neurobiological abnormalities that may exist in the
Pet1-Cre mice, Rosa26-DTR mice and/or Tph2flox/flox mice. In
this study, we took advantage of the Pet1-driven Cre expres-
sion to deplete central serotonergic neurons, and this may not
directly affect the survival of non-serotonergic neurons, but
may affect their function as serotonergic neurons have func-
tional connections with these neurons (Liu et al., 2002). On the
other hand, it should be noted that the depletion of seroton-
ergic neurons in DT-treated PC/DTR mice may lead to some
degeneration-associated effects such as reactive gliosis, which may
be implicated in behavioral alterations observed. Thus, although
multiple mouse lines were used to address the relationship
between the central 5-HT deficiency and anxiety- or depression-
like behaviors, we could not exclude the possibility that the
effects on these behavioral performances are caused indirectly
by possible compensations and other unknown changes that
are associated with the loss of 5-HT transmitter or serotonergic
neurons.
CONCLUSION
In summary, reduced anxiety-like but unchanged depression-
like behaviors were observed in the two central 5-HT-deficient
mice lacking either 5-HT itself or serotonergic neurons. We
generated a novel mouse model in which the central seroton-
ergic neurons and pancreatic islet cells were depleted in adult-
hood. These mice exhibited typical symptoms of diabetes mel-
litus, increased anxiety-like but a lower level of depression-like
behaviors, and increased adult hippocampal neurogenesis. Our
results suggest that 5-HT deficiency may not be sufficient to
induce anxiety/depression-like behaviors in mice, and enhanced
hippocampal neurogenesis may contribute to the absence of
depression-like behaviors in central 5-HT-deficient mice with
diabetes mellitus.
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